MYDA Advisors’s Celularity CELU Stock Holding History

MYDA Advisors’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,046	Closed	-$1.1M	–	295
2020 Q4	$1.1M	Buy	+10,046	New	+$1.07M	0.33%	73

Other funds holding CELU

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

MYDA Advisors's CELU Position: Q1 2021 in Review

MYDA Advisors sold out of Celularity (CELU) in Q1 2021, closing a stake of 10,046 shares — an estimated $1.1M sold.

MYDA Advisors first reported a position in CELU in Q4 2020 and held it in 1 quarter. The position peaked at $1.1M in Q4 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

MYDA Advisors reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
MYDA Advisors sold 10,046 Celularity shares in Q1 2021, an estimated $1.1M.
MYDA Advisors first reported a position in Celularity in Q4 2020 and held it in 1 quarter.
MYDA Advisors's Celularity position peaked at $1.1M in Q4 2020.
63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on MYDA Advisors's 13F filing for Q1 2021, filed 12 May 2021.